UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Status of research and development of vaccines for chikungunya

Vaccine, 2016-06, Vol.34 (26), p.2976-2981

2016

Volltextzugriff (PDF)

Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics

Vaccine, 2019-11, Vol.37 (50), p.7391-7393

2019

Volltextzugriff (PDF)

Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction

Vaccine, 2015-04, Vol.33 (17), p.2015-2021

2015

Volltextzugriff (PDF)

Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group

Vaccine, 2021-01, Vol.39 (4), p.633-640

2021

Volltextzugriff (PDF)

Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers

Vaccine, 2020-07, Vol.38 (34), p.5393-5395

2020

Volltextzugriff (PDF)

Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics

Vaccine, 2019-11, Vol.37 (50), p.7394-7395

2019

Volltextzugriff (PDF)

Vaccine adjuvants: A priority for vaccine research

Vaccine, 2010-03, Vol.28 (12), p.2363-2366

2010

Volltextzugriff (PDF)

Dual use issues in research – A subject of increasing concern?

Vaccine, 2017-10, Vol.35 (44), p.5990-5994

2017

Volltextzugriff (PDF)

Ethics, pregnancy, and ZIKV vaccine research & development

Vaccine, 2017-12, Vol.35 (49), p.6819-6822

2017

Volltextzugriff (PDF)

Engineering immunity for next generation HIV vaccines: The intersection of bioengineering and immunology

Vaccine, 2020-01, Vol.38 (2), p.187-193

2020

Volltextzugriff (PDF)

Vaccines against sexually transmitted infections: The way forward

Vaccine, 2014-03, Vol.32 (14), p.1630-1637

2014

Volltextzugriff (PDF)

Gaps in knowledge and prospects for research of adjuvanted vaccines

Vaccine, 2015-06, Vol.33, p.B40-B43

2015

Volltextzugriff (PDF)

Global Vaccine and Immunization Research Forum: Opportunities and challenges in vaccine discovery, development, and delivery

Vaccine, 2016-03, Vol.34 (13), p.1489-1495

2016

Volltextzugriff (PDF)

Conducting vaccine clinical trials in sub-Saharan Africa: Operational challenges and lessons learned from the Meningitis Vaccine Project

Vaccine, 2012-11, Vol.30 (48), p.6859-6863

2012

Volltextzugriff (PDF)

Development of dengue DNA vaccines

Vaccine, 2011-09, Vol.29 (42), p.7261-7266

2011

Volltextzugriff (PDF)

Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter

Vaccine, 2016-01, Vol.34 (1), p.49-55

2016

Volltextzugriff (PDF)

Report of an NIAID workshop on dengue animal models

Vaccine, 2010-06, Vol.28 (26), p.4229-4234

2010

Volltextzugriff (PDF)

Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: What are the “cGMP”?

Vaccine, 2015-04, Vol.33 (15), p.1757-1766

2015

Volltextzugriff (PDF)

Maternal immunization efforts of the National Institutes of Health

Vaccine, 2015-11, Vol.33 (47), p.6380-6387

2015

Volltextzugriff (PDF)

Are Impact Factors corrupting truth and utility in biomedical research?

Vaccine, 2013-12, Vol.31 (51), p.6041-6042

2013

Volltextzugriff (PDF)

Distribution of carried pneumococcal clones in UK children following the introduction of the 7-valent pneumococcal conjugate vaccine: A 3-year cross-sectional population based analysis

Vaccine, 2013-06, Vol.31 (31), p.3187-3190

2013

Volltextzugriff (PDF)

mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials

Vaccine, 2019-05, Vol.37 (25), p.3326-3334

2019

Volltextzugriff (PDF)

The expanding vaccine development pipeline, 1995–2008

Vaccine, 2010-02, Vol.28 (5), p.1353-1356

2010

Volltextzugriff (PDF)

Misinformation and COVID-19 vaccine hesitancy

Vaccine, 2023-01, Vol.41 (1), p.136-144

2023

Volltextzugriff (PDF)

1 – 25 von 13.724

Suche als RSS-Feed

Aktive Filter

SpracheNorwegisch

PublikationsformZeitungsartikel

ThemaAged

Zeitschrift / SerieVaccine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13.722)
Mit Volltextzugriff
(13.724)

Publikationsform

Artikel
(13.723)
Reviews
(1)

Sprache

Englisch
(13.724)
Japanisch
(1.490)

Erscheinungsjahr

n.n

Thema

Immunology
(13.461)
Life Sciences & Biomedicine
(13.457)
Medicine, Research & Experimental
(13.457)
Research & Experimental Medicine
(13.457)
Science & Technology
(13.457)
Biological And Medical Sciences
(11.458)
Fundamental And Applied Biological Sciences. Psychology
(10.750)
Microbiology
(10.302)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(10.191)
Vaccines
(8.184)
Applied Microbiology
(7.715)
Animals
(7.347)
Humans
(7.145)
Allergy And Immunology
(6.414)
Female
(5.751)
Virology
(4.274)
Mice
(4.189)
Miscellaneous
(4.130)
Immunization
(3.919)
Medical Sciences
(3.282)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

IngentaConnect
(13.723)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(13.722)
Access via ScienceDirect (Elsevier)
(13.722)
MEDLINE
(12.749)
IngentaConnect Journals
(6.674)
Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
(3)
Access via Taylor & Francis
(2)
Journals@Ovid Ovid Full Text
(1)
Single Journals
(1)

4 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Vaccine. Vol. 6, No. 2. 1988
(17)
Archives Of Dermatology
(1)
Illumina Biological Content - Unstructured
(1)
Vaccines
(1)

Neu hinzugefügt

... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

Status of research and development of vaccines for chikungunya

Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics

Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction

Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group

Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers

Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics

Vaccine adjuvants: A priority for vaccine research

Dual use issues in research – A subject of increasing concern?

Ethics, pregnancy, and ZIKV vaccine research & development

Engineering immunity for next generation HIV vaccines: The intersection of bioengineering and immunology

Vaccines against sexually transmitted infections: The way forward

Gaps in knowledge and prospects for research of adjuvanted vaccines

Global Vaccine and Immunization Research Forum: Opportunities and challenges in vaccine discovery, development, and delivery

Conducting vaccine clinical trials in sub-Saharan Africa: Operational challenges and lessons learned from the Meningitis Vaccine Project

Development of dengue DNA vaccines

Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter

Report of an NIAID workshop on dengue animal models

Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: What are the “cGMP”?

Maternal immunization efforts of the National Institutes of Health

Are Impact Factors corrupting truth and utility in biomedical research?

Distribution of carried pneumococcal clones in UK children following the introduction of the 7-valent pneumococcal conjugate vaccine: A 3-year cross-sectional population based analysis

Corrigendum to “Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers” [Vaccine 26 (2008) 6671–6677]

mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials

The expanding vaccine development pipeline, 1995–2008

Misinformation and COVID-19 vaccine hesitancy

Aktive Filter

Suchergebnisse filtern